Microbial Products Market

Microbial Products Market Size by Type (Enzymes, Polysaccharides, Nutrients, Chemotherapeutic Agents, Antibiotics, and Vaccines), Source (Bacterial, Viral, and Fungi), Application (Pharmaceutical Diagnostics, and Biotechnology), End-User (Pharmaceutical Industries, Biotechnological Industries, Hospitals and Clinics, Diagnostic Labs, and Research and Academic Institutions), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2024 to 2033

Base Year: 2023 Historical Data: 2020-22
  • Report ID: TBI-14194
  • Published Date: Mar, 2024
  • Pages: 238
  • Category: Chemicals & Materials
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global microbial products market was valued at USD 160 billion in 2023 and grew at a CAGR of 6% from 2024 to 2033. The market is expected to reach USD 286.53 billion by 2033. The changing health and fitness trends are anticipated to favour the demand for microbial products, thereby contributing to the growth of the global microbial products market.

Market Introduction:

Microbial products are derived from the metabolic processes of microorganisms. Their applications span pharmaceuticals, agriculture, food, and environmental remediation. Examples include antibiotics like penicillin, enzymes like amylase, and biofuels like ethanol. These products are typically produced through fermentation processes in bioreactors. Renewable substrates like sugars or organic waste are utilized in the production. Microbial products are diverse given the wide range of metabolic capabilities of microorganisms, which enables the production of a vast array of compounds, from therapeutic drugs to biodegradable plastics. Microbial products are also renewable and biodegradable, offering environmentally sustainable alternatives. Their scalability allows for an easy transition from laboratory to industrial-scale production, making them economically viable. Microbial products contribute to sustainability, economic growth, and human well-being. In agriculture, microbial products offer safer and more eco-friendly alternatives to chemical pesticides and fertilizers. Microbial products also have applications in environmental remediation, with microorganisms utilized for bioremediation of polluted environments, wastewater treatment, and soil restoration.

Microbial Products Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • Ginkgo Bioworks, which is developing the industry-leading platform for cell programming and biosecurity, and OneOne Biosciences, a French business providing farmers with a full range of agricultural microbial solutions, announced a new collaboration. This agreement will accelerate OneOne's research and product development in agricultural microbial solutions. Ginkgo's strong ag biologicals infrastructure, biotechnological expertise, and Strain Optimisation Services will all be leveraged.

Market Dynamics:

Drivers

The increasing demand for microbial products across industries adopting sustainable alternatives – the growing concerns about sustainability, including climate change and pollution- encourages industries to seek eco-friendly alternatives. Microbial products offer renewable and biodegradable solutions, aligning with sustainability goals and reducing environmental impact. The increasing awareness about superfoods and other health and wellness trends will favour microbial-based supplements, probiotics, and functional foods catering to the rising demand for these products from modern consumers concerned about their health. Additionally, the agricultural sector's shift towards sustainable practices underscores the need for microbial alternatives to chemical inputs. Furthermore, microbial products utilize inexpensive raw materials and fermentation processes, reducing manufacturing costs and enhancing profitability and competitiveness. Changing consumer preferences towards natural and organic products drives demand for microbial solutions. Therefore, these factors combined are anticipated to drive the growth of the global microbial products market.

Restraints:

The high contamination risks of microbial products microbial fermentation processes are vulnerable to unwanted microorganisms, reducing product yield and quality. Additionally, the limited product range of microbial products also impedes the market’s growth. Scaling up microbial fermentation processes from laboratory to industrial-scale production presents technical challenges. This scale-up process requires careful optimization of environmental conditions to maintain optimal microbial growth and productivity, often resulting in increased capital and operating costs. Environmental conditions such as temperature, pH, and substrate availability influence microbial growth and productivity. Variations in these factors can impact product consistency and yield. Therefore, the high contamination risks of microbial products exacerbated by other conditions of production and packaging will limit the market’s growth.

  • Eight lots of cough syrup produced by Haleon, the maker of Robitussin, were voluntarily recalled because of microbiological contamination. The recall includes six lots of 4- and 8-ounce bottles of Robitussin Honey CF Max Day Adult and two lots of 8-ounce bottles of Robitussin Honey CF Max Adult.
Opportunities:

Biotechnological advancements expanding microbial product applications – Biotechnological breakthroughs, including genetic engineering, synthetic biology, and metabolic engineering, facilitate the optimization of microorganisms, further enhancing productivity and the synthesis of novel compounds. Furthermore, robust regulatory practices and oversight environments ensure the safety and efficacy of microbial products through rigorous evaluation processes. Preclinical and clinical trials assess product safety, quality, and performance, ensuring compliance with regulatory standards before market entry. Regulatory approval assures consumers and stakeholders, contributing to positive market growth. Therefore, biotechnological breakthroughs and comprehensive regulatory oversight will offer lucrative market growth opportunities during the forecast period.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global microbial products market, with a 42% market revenue share in 2023.

The United States has a thriving biotechnology sector supported by world-renowned research institutions, universities, and biotech companies, facilitating advancements and innovations in the market. Well-established regulatory agencies provide clear guidelines and pathways for the approval and commercialization of microbial products. This regulatory certainty facilitates investment for microbial product developers, driving the market’s growth. North America's strong manufacturing capabilities and infrastructure enable efficient production and scale-up of microbial products. The region's diverse industrial landscape, encompassing pharmaceuticals, agriculture, food and beverages, and environmental applications, creates a conducive environment for adopting and utilising microbial products across these sectors.

North America Region Microbial Products Market Share in 2023 - 42%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Following hundreds of field tests in 2023, BioConsortia revealed that the company has improved its nitrogen-fixing products for row crops. It has shown that they can efficiently replace significant amounts of nitrogen fertilizer while increasing yields. "Always-N" microorganisms outperform expected performance levels and show suitability in a broad range of crops. Results from field trials conducted in 2023 have verified that when nitrogen replacement levels from BioConsortia's seed treatment products were assessed in row crops such as maize, wheat, rice and cotton, they either met or surpassed performance expectations. This move validates the market for BioConsortia's nitrogen-fixing products and their ability to mitigate the global agricultural misuse and runoff of fertilizer, which negatively impacts the environment.
Type Segment Analysis

The type segment is divided into enzymes, polysaccharides, nutrients, chemotherapeutic agents, antibiotics, and vaccines. The enzymes segment dominated the market, with a market share of around 37% in 2023. enzymes facilitate a broad spectrum of biochemical reactions across various industries, including food, pharmaceuticals, textiles, and biofuels. Their innate ability to accelerate reactions without being consumed makes them highly efficient and cost-effective tools for industrial processes. Enzymes offer customization through genetic and protein engineering. This adaptability allows for the development of custom biocatalysts tailored to meet the needs of diverse applications. Enzymes are renowned for their environmentally friendly characteristics. Their biodegradability and renewable nature contribute to sustainable manufacturing practices, aligning with the growing demand for eco-conscious solutions. Enzymes often deliver cost savings and process efficiencies by reducing energy consumption, minimizing waste generation, and improving product quality.

Source Segment Analysis

The source segment is divided into bacterial, viral, and fungi. The bacterial segment dominated the market, with a market share of around 44% in 2023. Bacteria are the preferred, widely used, popular, and dominant source for microbial products due to their abundance, versatility, ease of cultivation, genetic manipulability, safety profile, and economic viability. Bacteria offer many potential microbial products, from enzymes and antibiotics to biofuels. Their fast growth rates and simple nutritional requirements make bacteria relatively easy to cultivate in large-scale fermentation processes, facilitating rapid and cost-effective production of microbial products. Bacterial-derived products find applications across various industries, including pharmaceuticals, biotechnology, agriculture, and environmental remediation, owing to their diverse metabolic capabilities. Additionally, bacteria offer economic advantages for microbial product development, such as low production costs, scalability, and rapid fermentation cycles.

Application Segment Analysis

The application segment is divided into pharmaceutical diagnostics and biotechnology. The biotechnology segment dominated, with a market share of around 66% in 2023. biotechnology enables the production of valuable compounds ranging from pharmaceuticals to biofuels. Biotechnological processes can be customized to meet specific needs. This flexibility allows for the production of various microbial products across various industries, from healthcare to agriculture. Biotechnology offers sustainable solutions to pressing global challenges. Biotechnological applications minimize environmental impact and contribute to a more sustainable future by utilising renewable feedstocks and biodegradable processes. Furthermore, biotechnology drives innovation through ongoing research and development efforts. Biotechnology's dominance in the application of microbial products stems from its versatility, sustainability, and capacity for innovation.

End-user Segment Analysis

The end-user segment is divided into pharmaceutical industries, biotechnological industries, hospitals and clinics, diagnostic labs, and research and academic institutions. The hospitals and clinics segment dominated the market, with a market share of around 38% in 2023. Hospitals and clinics are the dominant users of microbial products due to their critical role in infection control, patient care, diagnostic testing, sterilization, and hand hygiene. Microbial products are indispensable in healthcare settings, where preventing infections and maintaining sterile environments are paramount. Microbial products such as disinfectants, antiseptics, and sterilization agents are essential for cleaning surfaces, equipment, and instruments to reduce the spread of pathogens and protect patients and healthcare workers. Diagnostic testing in hospitals and clinics requires microbial products to identify infectious agents and monitor disease progression. Sterilization and decontamination processes are critical to maintaining safe and sterile environments in healthcare settings. Microbial products like hand sanitisers, hand soaps, and surgical hand scrubs containing antimicrobial agents help healthcare workers maintain hand hygiene and reduce the risk of transmitting infections to patients and colleagues.

  • At the R&D facility in Hyderabad, Sri BioAesthetics, an Integrated AgribioTech Centre recently established with an INR 30 crore investment, created three new microbial solutions for managing fertility and soil health.
Some of the Key Market Players:
  • Ajinomoto Co. Inc.
  • Amgen Inc.
  • BIOMÉRIEUX SA
  • GlaxoSmithKline plc.
  • Merck & Co. Inc.
  • NOVADIGM Therapeutics
  • Novartis AG
  • Pfizer Inc.
  • SANOFI S.A
  • VALENT Biosciences Corp.

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2023 USD 160 Billion
Market size value in 2033 USD 286.53 Billion
CAGR (2024 to 2033) 6%
Historical data 2020-2022
Base Year 2023
Forecast 2024-2033
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level.
Segments Type, Source, Application and End User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the global microbial products market was valued at USD 160 billion in 2023 to USD 286.53 billion by 2033.

Global microbial products market is growing at a CAGR of 6% during the forecast period 2024-2033.

The market's growth will be influenced by the increasing demand for microbial products across industries adopting sustainable alternatives.

The high contamination risks of microbial products could hamper the market growth.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. The Brainy Insights has segmented the global microbial products market based on below mentioned segments:

Global Microbial Products Market by Type:

  • Enzymes
  • Polysaccharides
  • Nutrients
  • Chemotherapeutic Agents
  • Antibiotics
  • Vaccines

Global Microbial Products Market by Source:

  • Bacterial
  • Viral
  • Fungi

Global Microbial Products Market by Application:

  • Pharmaceutical Diagnostics
  • Biotechnology

Global Microbial Products Market by End User:

  • Pharmaceutical Industries
  • Biotechnological Industries
  • Hospitals and Clinics
  • Diagnostic Labs
  • Research and Academic Institutions

Global Microbial Products Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date